BIOGEN INC. DL -,0005 | 263.000 / +0.21% |
Date/Time | 02/03 / 21:43 |
Chg. / Chg.(%) | 0.550 / +0.21% |
Bid | 262.750 / 96 |
Ask | 262.900 / 96 |
Open | 261.550 |
Previous Close | 262.450 |
High | 267.450 |
Low | 261.550 |
Volume [EUR] | 33,446.650 |
Volume [Units] | 127 |
Price fixings | 36 |
ISIN | US09062X1037 |
Security | IDP |
Exchange | gettex |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 283.6300 | ![]() |
789,153 |
Cboe US | 283.82 | ![]() |
40,957 |
IEX | 283.64 | ![]() |
28,555 |
Stuttgart | 265.750 | ![]() |
738 |
TradeGate | 262.150 | ![]() |
646 |
Xetra | 264.75 | ![]() |
629 |
London Domes.. | 286.24 | ![]() |
368 |
gettex | 263.000 | ![]() |
127 |
Vienna Globa.. | 264.60 | ![]() |
41 |
Frankfurt | 263.9500 | ![]() |
10 |
München | 261.50 | ![]() |
0 |
Hamburg | 261.50 | ![]() |
0 |
Düsseldorf | 260.80 | ![]() |
0 |
Berlin | 262.90 | ![]() |
0 |
Hannover | 261.50 | ![]() |
0 |
Quotrix | 259.9000 | ![]() |
|
Lang & Schwa.. | 261.900 |
News
- FDA approves drug for early Alzheimer's treatment
01/06/2023 / 21:10 - TeleTrader - Wall Street extends losses on rate talks, China unrest
11/28/2022 / 19:15 - TeleTrader - Biogen falls 5% after death in Alzheimer's drug trial
11/28/2022 / 13:40 - TeleTrader - Biogen's EPS sees annual jump of 253% in Q3
10/25/2022 / 13:05 - TeleTrader - Biogen's Q2 EPS soar by 142.14% to $7.24 per share
07/20/2022 / 13:01 - TeleTrader
Personal area
Click on
to activate push quotes.
